ALPHAPRO Trademark
Trademark Overview
On Thursday, May 25, 2023, a trademark application was filed for ALPHAPRO with the United States Patent and Trademark Office. The USPTO has given the ALPHAPRO trademark a serial number of 98013156. The federal status of this trademark filing is NOTICE OF ALLOWANCE - ISSUED as of Tuesday, November 19, 2024. This trademark is owned by ARTBIO, Inc.. The ALPHAPRO trademark is filed in the Pharmaceutical Products, Medical Instrument Products, and Computer & Software Services & Scientific Services categories with the following description:
Drug delivery agents consisting of compounds that facilitate delivery of targeted radiation therapy; pharmaceutical preparations for use in targeted radiation therapy; pharmaceutical preparations for the treatment of cancer
Radiation therapy devices; implantable drug delivery devices, namely a radionuclide generator for targeted radiopharmaceutical therapy
Medical and scientific research in the areas of pharmaceutical products and radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields of immune modulation, infection, injury, inflammation, oncology/cancer, radiology, infectious, genetic, and autoimmune diseases, and radiation therapies; pharmaceutical and biotechnological research and development in the field of targeted radiation therapy
General Information
| Serial Number | 98013156 |
| Word Mark | ALPHAPRO |
| Filing Date | Thursday, May 25, 2023 |
| Status | 688 - NOTICE OF ALLOWANCE - ISSUED |
| Status Date | Tuesday, November 19, 2024 |
| Registration Number | 0000000 |
| Registration Date | NOT AVAILABLE |
| Mark Drawing | 4 - Illustration: Drawing with word(s) / letter(s) / number(s) in Block form |
| Published for Opposition Date | Tuesday, August 13, 2024 |
Trademark Statements
| Goods and Services | Drug delivery agents consisting of compounds that facilitate delivery of targeted radiation therapy; pharmaceutical preparations for use in targeted radiation therapy; pharmaceutical preparations for the treatment of cancer |
| Goods and Services | Radiation therapy devices; implantable drug delivery devices, namely a radionuclide generator for targeted radiopharmaceutical therapy |
| Goods and Services | Medical and scientific research in the areas of pharmaceutical products and radiation therapy for the prevention and treatment of medical conditions; pharmaceutical and biotechnological research and development in the fields of immune modulation, infection, injury, inflammation, oncology/cancer, radiology, infectious, genetic, and autoimmune diseases, and radiation therapies; pharmaceutical and biotechnological research and development in the field of targeted radiation therapy |
Classification Information
| International Class | 005 - Pharmaceutical and veterinary preparations; sanitary preparations for medical purposes; dietetic substances adapted for medical use, food for babies; plasters, materials for dressings; material for stopping teeth, dental wax; disinfectants; preparations for destroying vermin; fungicides, herbicides. |
| US Class Codes | 005, 006, 018, 044, 046, 051, 052 |
| Class Status Code | 6 - Active |
| Class Status Date | Monday, June 26, 2023 |
| Primary Code | 005 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 010 - Surgical, medical, dental, and veterinary apparatus and instruments, artificial limbs, eyes, and teeth; orthopedic articles; suture materials. |
| US Class Codes | 026, 039, 044 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 8, 2024 |
| Primary Code | 010 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
| International Class | 042 - Scientific and technological services and research and design relating thereto; industrial analysis and research services; design and development of computer hardware and software. |
| US Class Codes | 100, 101 |
| Class Status Code | 6 - Active |
| Class Status Date | Friday, March 8, 2024 |
| Primary Code | 042 |
| First Use Anywhere Date | NOT AVAILABLE |
| First Use In Commerce Date | NOT AVAILABLE |
Trademark Owner History
| Party Name | ARTBIO, Inc. |
| Party Type | 20 - Owner at Publication |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
| Party Name | ARTBIO, Inc. |
| Party Type | 10 - Original Applicant |
| Legal Entity Type | 03 - Corporation |
| Address | Cambridge, MA 02142 |
Trademark Events
| Event Date | Event Description |
| Monday, February 19, 2024 | NOTIFICATION OF NON-FINAL ACTION E-MAILED |
| Monday, June 26, 2023 | NEW APPLICATION OFFICE SUPPLIED DATA ENTERED |
| Monday, February 19, 2024 | ASSIGNED TO EXAMINER |
| Monday, February 19, 2024 | NON-FINAL ACTION WRITTEN |
| Monday, February 19, 2024 | NON-FINAL ACTION E-MAILED |
| Friday, March 8, 2024 | TEAS RESPONSE TO OFFICE ACTION RECEIVED |
| Friday, March 8, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, March 8, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Tuesday, March 26, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, April 9, 2024 | WITHDRAWN FROM PUB - OG REVIEW QUERY |
| Friday, April 12, 2024 | PREVIOUS ALLOWANCE COUNT WITHDRAWN |
| Friday, June 28, 2024 | TEAS/EMAIL CORRESPONDENCE ENTERED |
| Friday, June 28, 2024 | CORRESPONDENCE RECEIVED IN LAW OFFICE |
| Friday, April 12, 2024 | FINAL REFUSAL WRITTEN |
| Friday, April 12, 2024 | FINAL REFUSAL E-MAILED |
| Friday, April 12, 2024 | NOTIFICATION OF FINAL REFUSAL EMAILED |
| Friday, June 28, 2024 | TEAS REQUEST FOR RECONSIDERATION RECEIVED |
| Wednesday, July 24, 2024 | NOTIFICATION OF NOTICE OF PUBLICATION E-MAILED |
| Thursday, July 4, 2024 | APPROVED FOR PUB - PRINCIPAL REGISTER |
| Tuesday, September 10, 2024 | EXTENSION OF TIME TO OPPOSE RECEIVED |
| Wednesday, October 23, 2024 | EXTENSION OF TIME TO OPPOSE PROCESS - TERMINATED |
| Tuesday, November 19, 2024 | NOA E-MAILED - SOU REQUIRED FROM APPLICANT |
| Tuesday, August 13, 2024 | PUBLISHED FOR OPPOSITION |
| Tuesday, August 13, 2024 | OFFICIAL GAZETTE PUBLICATION CONFIRMATION E-MAILED |
